Orphazyme Aps

Developer of therapeutics for the treatment of rare and genetic diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2009 groups141 employees language orphazyme.com

Registered entities

Innovation

9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 935 times.

YearFilings
20122
20133
20142
20153
20163
20175
20182
20192
20201
20214
20231

Investor mix

11 investors on record; lead investors include Kurma Partners, Life Sciences Partners, ALS Investment Fund; 1 has since exited.

Investor typeCountShare
Venture capital436%
Private equity436%
Accelerator & incubator19%
Bank & private debt19%
Other / undisclosed19%
Coming soon